Advertisement
Review Article| Volume 26, ISSUE 1, P59-91, January 2010

Diagnosis and Management of Infectious Complications in Critically Ill Patients with Cancer

  • Raghukumar Thirumala
    Affiliations
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, C1179, New York, NY 10021, USA
    Search for articles by this author
  • Madhusudanan Ramaswamy
    Affiliations
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, C1179, New York, NY 10021, USA
    Search for articles by this author
  • Sanjay Chawla
    Correspondence
    Corresponding author. Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, C1179, New York, NY 10021.
    Affiliations
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, C1179, New York, NY 10021, USA

    Department of Clinical Anesthesiology, Weill Cornell Medical College, New York, NY, USA
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Martin G.S.
        • Mannino D.M.
        • Eaton S.
        • et al.
        The epidemiology of sepsis in the United States from 1979 through 2000.
        N Engl J Med. 2003; 348: 1546-1554
        • Danai P.A.
        • Moss M.
        • Mannino D.M.
        • et al.
        The epidemiology of sepsis in patients with malignancy.
        Chest. 2006; 129: 1432-1440
        • Safdar A.
        • Armstrong D.
        Infectious morbidity in critically ill patients with cancer.
        Crit Care Clin. 2001; 17 (vii–viii): 531-570
        • Angus D.C.
        • Linde-Zwirble W.T.
        • Lidicker J.
        • et al.
        Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.
        Crit Care Med. 2001; 29: 1303-1310
        • Williams M.D.
        • Braun L.A.
        • Cooper L.M.
        • et al.
        Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care.
        Crit Care. 2004; 8: R291-R298
        • American Cancer Society
        Cancer facts & figures 2009.
        American Cancer Society, Atlanta (GA)2009 (Available at:) (Accessed June 21, 2009)
        • Jemal A.
        • Siegel R.
        • Ward E.
        • et al.
        Cancer statistics, 2009.
        CA Cancer J Clin. 2009; 59: 225-249
        • Pene F.
        • Percheron S.
        • Lemiale V.
        • et al.
        Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit.
        Crit Care Med. 2008; 36: 690-696
        • Taccone F.S.
        • Artigas A.A.
        • Sprung C.L.
        • et al.
        Characteristics and outcomes of cancer patients in European ICUs.
        Crit Care. 2009; 13: R15
        • Hubel K.
        • Hegener K.
        • Schnell R.
        • et al.
        Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia.
        Ann Hematol. 1999; 78: 73-77
        • Pickering L.K.
        • Ericsson C.D.
        • Kohl S.
        Effect of chemotherapeutic agents on metabolic and bactericidal activity of polymorphonuclear leukocytes.
        Cancer. 1978; 42: 1741-1746
        • Vaudaux P.
        • Kiefer B.
        • Forni M.
        • et al.
        Adriamycin impairs phagocytic function and induces morphologic alterations in human neutrophils.
        Cancer. 1984; 54: 400-410
        • Bhatt V.
        • Saleem A.
        Review: drug-induced neutropenia–pathophysiology, clinical features, and management.
        Ann Clin Lab Sci. 2004; 34: 131-137
        • Mac Manus M.
        • Lamborn K.
        • Khan W.
        • et al.
        Radiotherapy-associated neutropenia and thrombocytopenia: analysis of risk factors and development of a predictive model.
        Blood. 1997; 89: 2303-2310
        • Gallacher S.J.
        • Thomson G.
        • Fraser W.D.
        • et al.
        Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control.
        Diabet Med. 1995; 12: 916-920
        • Turina M.
        • Fry D.E.
        • Polk Jr., H.C.
        Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects.
        Crit Care Med. 2005; 33: 1624-1633
        • Chanock S.J.
        • Pizzo P.A.
        Infectious complications of patients undergoing therapy for acute leukemia: current status and future prospects.
        Semin Oncol. 1997; 24: 132-140
        • Bodey G.P.
        • Buckley M.
        • Sathe Y.S.
        • et al.
        Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.
        Ann Intern Med. 1966; 64: 328-340
        • Deinard A.S.
        • Fortuny I.E.
        • Theologides A.
        • et al.
        Studies on the neutropenia of cancer chemotherapy.
        Cancer. 1974; 33: 1210-1218
        • Lalami Y.
        • Paesmans M.
        • Muanza F.
        • et al.
        Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis.
        Ann Oncol. 2006; 17: 507-514
        • Marshall J.C.
        • Charbonney E.
        • Gonzalez P.D.
        The immune system in critical illness.
        Clin Chest Med. 2008; 29 (vii): 605-616
        • Frank M.M.
        • Joiner K.
        • Hammer C.
        The function of antibody and complement in the lysis of bacteria.
        Rev Infect Dis. 1987; 9: S537-S545
        • Wadhwa P.D.
        • Morrison V.A.
        Infectious complications of chronic lymphocytic leukemia.
        Semin Oncol. 2006; 33: 240-249
        • Paradisi F.
        • Corti G.
        • Cinelli R.
        Infections in multiple myeloma.
        Infect Dis Clin North Am. 2001; 15 (vii–viii): 373-384
        • Fahey J.L.
        • Scoggins R.
        • Utz J.P.
        • et al.
        Infection, antibody response and gamma globulin components in multiple myeloma and macroglobulinemia.
        Am J Med. 1963; 35: 698-707
        • Tabbara I.A.
        • Zimmerman K.
        • Morgan C.
        • et al.
        Allogeneic hematopoietic stem cell transplantation: complications and results.
        Arch Intern Med. 2002; 162: 1558-1566
        • Notter D.T.
        • Grossman P.L.
        • Rosenberg S.A.
        • et al.
        Infections in patients with Hodgkin's disease: a clinical study of 300 consecutive adult patients.
        Rev Infect Dis. 1980; 2: 761-800
        • Plosker G.L.
        • Figgitt D.P.
        Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
        Drugs. 2003; 63: 803-843
        • Martin S.I.
        • Marty F.M.
        • Fiumara K.
        • et al.
        Infectious complications associated with alemtuzumab use for lymphoproliferative disorders.
        Clin Infect Dis. 2006; 43: 16-24
        • Otahbachi M.
        • Nugent K.
        • Buscemi D.
        Granulomatous Pneumocystis jiroveci Pneumonia in a patient with chronic lymphocytic leukemia: a literature review and hypothesis on pathogenesis.
        Am J Med Sci. 2007; 333: 131-135
        • Wucherpfennig K.W.
        T-cell immunity.
        in: Hoffman R. Hematology: basic principles and practice. 5th edition. Churchill Livingstone/Elsevier, Philadelphia2009: 117-127
        • Fisher R.I.
        • DeVita Jr., V.T.
        • Bostick F.
        • et al.
        Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease.
        Ann Intern Med. 1980; 92: 595-599
        • Mahieux R.
        • Gessain A.
        HTLV-1 and associated adult T-cell leukemia/lymphoma.
        Rev Clin Exp Hematol. 2003; 7: 336-361
        • Bodey G.P.
        Infection in cancer patients. A continuing association.
        Am J Med. 1986; 81: 11-26
        • Anaissie E.J.
        • Kontoyiannis D.P.
        • O'Brien S.
        • et al.
        Infections in patients with chronic lymphocytic leukemia treated with fludarabine.
        Ann Intern Med. 1998; 129: 559-566
        • Mackall C.L.
        • Fleisher T.A.
        • Brown M.R.
        • et al.
        Lymphocyte depletion during treatment with intensive chemotherapy for cancer.
        Blood. 1994; 84: 2221-2228
        • Schilling P.J.
        • Vadhan-Raj S.
        Concurrent cytomegalovirus and pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia.
        N Engl J Med. 1990; 323: 833-834
        • Su Y.B.
        • Sohn S.
        • Krown S.E.
        • et al.
        Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications.
        J Clin Oncol. 2004; 22: 610-616
        • Yu S.K.
        • Chalmers A.J.
        Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia.
        Clin Oncol (R Coll Radiol). 2007; 19: 631-632
        • Sickles E.A.
        • Greene W.H.
        • Wiernik P.H.
        Clinical presentation of infection in granulocytopenic patients.
        Arch Intern Med. 1975; 135: 715-719
        • Crawford J.
        • Dale D.C.
        • Lyman G.H.
        Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.
        Cancer. 2004; 100: 228-237
        • Hughes W.T.
        • Armstrong D.
        • Bodey G.P.
        • et al.
        2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.
        Clin Infect Dis. 2002; 34: 730-751
        • Heussel C.P.
        • Kauczor H.U.
        • Heussel G.E.
        • et al.
        Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography.
        J Clin Oncol. 1999; 17: 796-805
        • Mermel L.A.
        • Farr B.M.
        • Sherertz R.J.
        • et al.
        Guidelines for the management of intravascular catheter-related infections.
        Clin Infect Dis. 2001; 32: 1249-1272
        • Klastersky J.
        Antifungal therapy in patients with fever and neutropenia–more rational and less empirical?.
        N Engl J Med. 2004; 351: 1445-1447
        • Talcott J.A.
        • Siegel R.D.
        • Finberg R.
        • et al.
        Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.
        J Clin Oncol. 1992; 10: 316-322
        • Klastersky J.
        • Paesmans M.
        • Rubenstein E.B.
        • et al.
        The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients.
        J Clin Oncol. 2000; 18: 3038-3051
        • Wisplinghoff H.
        • Seifert H.
        • Wenzel R.P.
        • et al.
        Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.
        Clin Infect Dis. 2003; 36: 1103-1110
        • Rolston Kvi R.I.
        • Whimbey E.
        • Bodey G.P.
        The changing spectrum of bacterial infections in febrile neutropenic patients.
        in: Klastersky J. Febrile neutropenia. Springer-Verlag, New York1997: 53-56 (Berlin (Germany))
        • Elting L.S.
        • Bodey G.P.
        • Keefe B.H.
        Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.
        Clin Infect Dis. 1992; 14: 1201-1207
        • Lecciones J.A.
        • Lee J.W.
        • Navarro E.E.
        • et al.
        Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes.
        Clin Infect Dis. 1992; 14: 875-883
        • Kontoyiannis D.P.
        • Bodey G.P.
        Invasive aspergillosis in 2002: an update.
        Eur J Clin Microbiol Infect Dis. 2002; 21: 161-172
        • Morrison V.A.
        • Haake R.J.
        • Weisdorf D.J.
        Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome.
        Am J Med. 1994; 96: 497-503
        • Caillot D.
        • Couaillier J.F.
        • Bernard A.
        • et al.
        Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia.
        J Clin Oncol. 2001; 19: 253-259
        • Cometta A.
        • Calandra T.
        • Gaya H.
        • et al.
        Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.
        Antimicrob Agents Chemother. 1996; 40: 1108-1115
        • Johnson M.P.
        • Ramphal R.
        Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy.
        J Infect Dis. 1990; 162: 981-983
        • Stroncek D.
        • Shawker T.
        • Follmann D.
        • et al.
        G-CSF-induced spleen size changes in peripheral blood progenitor cell donors.
        Transfusion. 2003; 43: 609-613
        • Maschmeyer G.
        • Link H.
        • Hiddemann W.
        • et al.
        Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study.
        Cancer. 1994; 73: 2296-2304
        • Crawford S.W.
        Noninfectious lung disease in the immunocompromised host.
        Respiration. 1999; 66: 385-395
        • Jain P.
        • Sandur S.
        • Meli Y.
        • et al.
        Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates.
        Chest. 2004; 125: 712-722
        • Bodey G.P.
        • Rodriguez V.
        • Chang H.Y.
        • et al.
        Fever and infection in leukemic patients: a study of 494 consecutive patients.
        Cancer. 1978; 41: 1610-1622
        • Bochud P.Y.
        • Calandra T.
        • Francioli P.
        Bacteremia due to viridans streptococci in neutropenic patients: a review.
        Am J Med. 1994; 97: 256-264
        • Jacobson K.L.
        • Miceli M.H.
        • Tarrand J.J.
        • et al.
        Legionella pneumonia in cancer patients.
        Medicine (Baltimore). 2008; 87: 152-159
        • Fujita J.
        • Yamadori I.
        • Xu G.
        • et al.
        Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients.
        Respir Med. 1996; 90: 35-38
        • Venditti M.
        • Monaco M.
        • Micozzi A.
        • et al.
        In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
        Clin Microbiol Infect. 2001; 7: 37-39
        • Safdar A.
        • Rolston K.V.
        Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.
        Clin Infect Dis. 2007; 45: 1602-1609
        • Traub W.H.
        • Leonhard B.
        • Bauer D.
        Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
        Chemotherapy. 1998; 44: 293-304
        • Martinez Tomas R.
        • Menendez Villanueva R.
        • Reyes Calzada S.
        • et al.
        Pulmonary nocardiosis: risk factors and outcomes.
        Respirology. 2007; 12: 394-400
        • Shima T.
        • Yoshimoto G.
        • Miyamoto T.
        • et al.
        Disseminated tuberculosis following second unrelated cord blood transplantation for acute myelogenous leukemia.
        Transpl Infect Dis. 2009; 11: 75-77
        • Blumberg H.M.
        • et al.
        Treatment of tuberculosis.
        MMWR Recomm Rep. 2003; 52: 1-77
        • Reilly A.F.
        • McGowan K.L.
        Atypical mycobacterial infections in children with cancer.
        Pediatr Blood Cancer. 2004; 43: 698-702
        • Meeuse J.J.
        • Sprenger H.G.
        • van Assen S.
        • et al.
        Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia.
        Emerg Infect Dis. 2007; 13: 1942-1943
        • Casetta M.
        • Blot F.
        • Antoun S.
        • et al.
        Diagnosis of nosocomial pneumonia in cancer patients undergoing mechanical ventilation: a prospective comparison of the plugged telescoping catheter with the protected specimen brush.
        Chest. 1999; 115: 1641-1645
        • Chemaly R.F.
        • Ghosh S.
        • Bodey G.P.
        • et al.
        Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center.
        Medicine (Baltimore). 2006; 85: 278-287
        • Whimbey E.
        • Englund J.A.
        • Couch R.B.
        Community respiratory virus infections in immunocompromised patients with cancer.
        Am J Med. 1997; 102 ([discussion: 25–6]): 10-18
        • Torres H.A.
        • Aguilera E.A.
        • Mattiuzzi G.N.
        • et al.
        Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia.
        Haematologica. 2007; 92: 1216-1223
        • Khanna N.
        • Widmer A.F.
        • Decker M.
        • et al.
        Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
        Clin Infect Dis. 2008; 46: 402-412
        • Boeckh M.
        • Berrey M.M.
        • Bowden R.A.
        • et al.
        Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.
        J Infect Dis. 2001; 184: 350-354
        • Nguyen Q.
        • Estey E.
        • Raad I.
        • et al.
        Cytomegalovirus pneumonia in adults with leukemia: an emerging problem.
        Clin Infect Dis. 2001; 32: 539-545
        • Crawford S.W.
        • Bowden R.A.
        • Hackman R.C.
        • et al.
        Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture.
        Ann Intern Med. 1988; 108: 180-185
        • de la Hoz R.E.
        • Stephens G.
        • Sherlock C.
        Diagnosis and treatment approaches of CMV infections in adult patients.
        J Clin Virol. 2002; 25: S1-12
        • Schuller D.
        • Spessert C.
        • Fraser V.J.
        • et al.
        Herpes simplex virus from respiratory tract secretions: epidemiology, clinical characteristics, and outcome in immunocompromised and nonimmunocompromised hosts.
        Am J Med. 1993; 94: 29-33
        • Connolly Jr., M.G.
        • Baughman R.P.
        • Dohn M.N.
        • et al.
        Recovery of viruses other than cytomegalovirus from bronchoalveolar lavage fluid.
        Chest. 1994; 105: 1775-1781
        • Pierangeli A.
        • Gentile M.
        • Di Marco P.
        • et al.
        Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy.
        J Med Virol. 2007; 79: 463-468
        • Parody R.
        • Rabella N.
        • Martino R.
        • et al.
        Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies.
        Am J Hematol. 2007; 82: 807-811
        • Kamboj M.
        • Gerbin M.
        • Huang C.K.
        • et al.
        Clinical characterization of human metapneumovirus infection among patients with cancer.
        J Infect. 2008; 57: 464-471
        • Kamble R.T.
        • Bollard C.
        • Demmler G.
        • et al.
        Human metapneumovirus infection in a hematopoietic transplant recipient.
        Bone Marrow Transplant. 2007; 40: 699-700
        • Lin S.J.
        • Schranz J.
        • Teutsch S.M.
        Aspergillosis case-fatality rate: systematic review of the literature.
        Clin Infect Dis. 2001; 32: 358-366
        • Subira M.
        • Martino R.
        • Franquet T.
        • et al.
        Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.
        Haematologica. 2002; 87: 528-534
        • Reichenberger F.
        • Habicht J.M.
        • Gratwohl A.
        • et al.
        Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients.
        Eur Respir J. 2002; 19: 743-755
        • Buchheidt D.
        • Baust C.
        • Skladny H.
        • et al.
        Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients.
        Br J Haematol. 2002; 116: 803-811
        • Ascioglu S.
        • Rex J.H.
        • de Pauw B.
        • et al.
        Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
        Clin Infect Dis. 2002; 34: 7-14
        • Zedek D.C.
        • Miller M.B.
        Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period.
        J Clin Microbiol. 2006; 44: 1601
        • Walsh T.J.
        • Pappas P.
        • Winston D.J.
        • et al.
        Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
        N Engl J Med. 2002; 346: 225-234
        • Prentice H.G.
        • Hann I.M.
        • Herbrecht R.
        • et al.
        A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
        Br J Haematol. 1997; 98: 711-718
        • Herbrecht R.
        • Denning D.W.
        • Patterson T.F.
        • et al.
        Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
        N Engl J Med. 2002; 347: 408-415
        • Walsh T.J.
        • Raad I.
        • Patterson T.F.
        • et al.
        Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
        Clin Infect Dis. 2007; 44: 2-12
        • Maertens J.
        • Raad I.
        • Petrikkos G.
        • et al.
        Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
        Clin Infect Dis. 2004; 39: 1563-1571
        • Todeschini G.
        • Murari C.
        • Bonesi R.
        • et al.
        Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications.
        Eur J Clin Invest. 1999; 29: 453-457
        • Vento S.
        • Cainelli F.
        • Temesgen Z.
        Lung infections after cancer chemotherapy.
        Lancet Oncol. 2008; 9: 982-992
        • Morris A.
        • Lundgren J.D.
        • Masur H.
        • et al.
        Current epidemiology of Pneumocystis pneumonia.
        Emerg Infect Dis. 2004; 10: 1713-1720
        • Torres H.A.
        • Chemaly R.F.
        • Storey R.
        • et al.
        Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients.
        Eur J Clin Microbiol Infect Dis. 2006; 25: 382-388
        • Limper A.H.
        • Offord K.P.
        • Smith T.F.
        • et al.
        Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS.
        Am Rev Respir Dis. 1989; 140: 1204-1209
        • Morris A.
        Is there anything new in Pneumocystis jiroveci pneumonia? Changes in P. jirovecii pneumonia over the course of the AIDS epidemic.
        Clin Infect Dis. 2008; 46: 634-636
        • Pagano L.
        • Fianchi L.
        • Mele L.
        • et al.
        Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.
        Br J Haematol. 2002; 117: 379-386
        • Green H.
        • Paul M.
        • Vidal L.
        • et al.
        Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
        Cochrane Database Syst Rev. 2007; (CD005590)
        • Keiser P.B.
        • Nutman T.B.
        Strongyloides stercoralis in the Immunocompromised Population.
        Clin Microbiol Rev. 2004; 17: 208-217
        • Davila M.L.
        Neutropenic enterocolitis: current issues in diagnosis and management.
        Curr Infect Dis Rep. 2007; 9: 116-120
        • Urbach D.R.
        • Rotstein O.D.
        Typhlitis.
        Can J Surg. 1999; 42: 415-419
        • Gorschluter M.
        • Mey U.
        • Strehl J.
        • et al.
        Neutropenic enterocolitis in adults: systematic analysis of evidence quality.
        Eur J Haematol. 2005; 75: 1-13
        • Baerg J.
        • Murphy J.J.
        • Anderson R.
        • et al.
        Neutropenic enteropathy: a 10-year review.
        J Pediatr Surg. 1999; 34: 1068-1071
        • Gorschluter M.
        • Mey U.
        • Strehl J.
        • et al.
        Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients.
        BMC Infect Dis. 2006; 6: 35
        • Baden L.R.
        • Maguire J.H.
        Gastrointestinal infections in the immunocompromised host.
        Infect Dis Clin North Am. 2001; 15 (xi): 639-670
        • Kirkpatrick I.D.
        • Greenberg H.M.
        Gastrointestinal complications in the neutropenic patient: characterization and differentiation with abdominal CT.
        Radiology. 2003; 226: 668-674
        • Cartoni C.
        • Dragoni F.
        • Micozzi A.
        • et al.
        Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography.
        J Clin Oncol. 2001; 19: 756-761
        • Smith T.J.
        • Khatcheressian J.
        • Lyman G.H.
        • et al.
        2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.
        J Clin Oncol. 2006; 24: 3187-3205
        • Leffler D.A.
        • Lamont J.T.
        Treatment of Clostridium difficile-associated disease.
        Gastroenterology. 2009; 136: 1899-1912
        • Rupnik M.
        • Wilcox M.H.
        • Gerding D.N.
        Clostridium difficile infection: new developments in epidemiology and pathogenesis.
        Nat Rev Microbiol. 2009; 7: 526-536
        • Gorschluter M.
        • Glasmacher A.
        • Hahn C.
        • et al.
        Clostridium difficile Infection in patients with Neutropenia.
        Clin Infect Dis. 2001; 33: 786-791
        • Fenner L.
        • Widmer A.F.
        • Goy G.
        • et al.
        Rapid and reliable diagnostic algorithm for detection of Clostridium difficile.
        J Clin Microbiol. 2008; 46: 328-330
        • Johnson S.
        • Gerding D.N.
        Clostridium difficile–associated diarrhea.
        Clin Infect Dis. 1998; 26 (quiz 35–6): 1027-1034
        • Gerding D.N.
        • Muto C.A.
        • Owens Jr., R.C.
        Treatment of Clostridium difficile infection.
        Clin Infect Dis. 2008; 46: S32-S42
        • Kontoyiannis D.P.
        • Luna M.A.
        • Samuels B.I.
        • et al.
        Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis.
        Infect Dis Clin North Am. 2000; 14: 721-739
        • Pappas P.G.
        Invasive candidiasis.
        Infect Dis Clin North Am. 2006; 20: 485-506
        • Pappas P.G.
        • Kauffman C.A.
        • Andes D.
        • et al.
        Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
        Clin Infect Dis. 2009; 48: 503-535
        • DeAngelis L.M.
        • Posner J.B.
        Central nervous system infections.
        in: DeAngelis L.M. Posner J.B. Neurologic complications of cancer. 2nd edition. Oxford University Press, Oxford (UK)/New York2009: 369-416
        • Pruitt A.A.
        Central nervous system infections in cancer patients.
        Semin Neurol. 2004; 24: 435-452
        • Safdieh J.E.
        • Mead P.A.
        • Sepkowitz K.A.
        • et al.
        Bacterial and fungal meningitis in patients with cancer.
        Neurology. 2008; 70: 943-947
        • Pruitt A.A.
        Nervous system infections in patients with cancer.
        Neurol Clin. 2003; 21: 193-219
        • Huang S.H.
        • Jong A.Y.
        Cellular mechanisms of microbial proteins contributing to invasion of the blood-brain barrier.
        Cell Microbiol. 2001; 3: 277-287
        • Mylonakis E.
        • Hohmann E.L.
        • Calderwood S.B.
        Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature.
        Medicine (Baltimore). 1998; 77: 313-336
        • Lukes S.A.
        • Posner J.B.
        • Nielsen S.
        • et al.
        Bacterial infections of the CNS in neutropenic patients.
        Neurology. 1984; 34: 269-275
        • Schwartz S.
        • Thiel E.
        Clinical presentation of invasive aspergillosis.
        Mycoses. 1997; 40: 21-24
        • Quadri T.L.
        • Brown A.E.
        Infectious complications in the critically ill patient with cancer.
        Semin Oncol. 2000; 27: 335-346
        • de Gans J.
        • van de Beek D.
        Dexamethasone in adults with bacterial meningitis.
        N Engl J Med. 2002; 347: 1549-1556
        • van de Beek D.
        • de Gans J.
        • McIntyre P.
        • et al.
        Steroids in adults with acute bacterial meningitis: a systematic review.
        Lancet Infect Dis. 2004; 4: 139-143
        • Polsky B.
        • Depman M.R.
        • Gold J.W.
        • et al.
        Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir.
        Am J Med. 1986; 81: 24-28
        • Gottfredsson M.
        • Perfect J.R.
        Fungal meningitis.
        Semin Neurol. 2000; 20: 307-322
        • Raad I.
        • Hanna H.A.
        Long-term central venous catheters.
        in: Seifert H. Jansen B. Farr B.M. Catheter-related infections (infectious disease and therapy). 2nd edition. Marcel Dekker, New York2005: 425-444
        • Sherertz R.J.
        • Heard S.O.
        • Raad I.I.
        Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies.
        J Clin Microbiol. 1997; 35: 641-646
        • Maki D.G.
        • Mermel L.A.
        Infections due to infusion therapy.
        in: Bennett J.V. Brachman P.S. Hospital infections. 4th edition. Lippincott-Raven, Philadelphia1998: 689-724
        • Blot F.
        • Nitenberg G.
        • Chachaty E.
        • et al.
        Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures.
        Lancet. 1999; 354: 1071-1077
        • Capdevila J.A.
        • Planes A.M.
        • Palomar M.
        • et al.
        Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis.
        Eur J Clin Microbiol Infect Dis. 1992; 11: 403-407
        • Raad I.
        Management of intravascular catheter-related infections.
        J Antimicrob Chemother. 2000; 45: 267-270
        • Elting L.S.
        • Bodey G.P.
        Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections.
        Medicine (Baltimore). 1990; 69: 296-306
        • Raad I.I.
        • Vartivarian S.
        • Khan A.
        • et al.
        Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review.
        Rev Infect Dis. 1991; 13: 1120-1125
        • Rex J.H.
        • Walsh T.J.
        • Sobel J.D.
        • et al.
        Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
        Clin Infect Dis. 2000; 30: 662-678
        • Anaissie E.J.
        • Rex J.H.
        • Uzun O.
        • et al.
        Predictors of adverse outcome in cancer patients with candidemia.
        Am J Med. 1998; 104: 238-245
        • Raad I.
        • Narro J.
        • Khan A.
        • et al.
        Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients.
        Eur J Clin Microbiol Infect Dis. 1992; 11: 675-682
        • Verghese A.
        • Widrich W.C.
        • Arbeit R.D.
        Central venous septic thrombophlebitis–the role of medical therapy.
        Medicine (Baltimore). 1985; 64: 394-400
        • Nambirajan T.
        • O'Sullivan J.M.
        Genitourinary tract infections in cancer patients.
        in: Spence R.A.J. Hay R.J. Johnston P.G. Infection in the cancer patient: a practical guide. 1st edition. Oxford University Press, Oxford (UK)/New York2006: 101-112
        • DeVita V.T.
        • Lawrence T.S.
        • Rosenberg S.A.
        DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology.
        8th edition. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia2008
        • Stunell H.
        • Buckley O.
        • Feeney J.
        • et al.
        Imaging of acute pyelonephritis in the adult.
        Eur Radiol. 2007; 17: 1820-1828
        • Falagas M.E.
        • Vergidis P.I.
        Urinary tract infections in patients with urinary diversion.
        Am J Kidney Dis. 2005; 46: 1030-1037
        • Wood Jr., D.P.
        • Bianco Jr., F.J.
        • Pontes J.E.
        • et al.
        Incidence and significance of positive urine cultures in patients with an orthotopic neobladder.
        J Urol. 2003; 169: 2196-2199
        • Keegan S.J.
        • Graham C.
        • Neal D.E.
        • et al.
        Characterization of Escherichia coli strains causing urinary tract infections in patients with transposed intestinal segments.
        J Urol. 2003; 169: 2382-2387
        • Ganatra A.M.
        • Loughlin K.R.
        The management of malignant ureteral obstruction treated with ureteral stents.
        J Urol. 2005; 174: 2125-2128
        • Rosenberg B.H.
        • Bianco Jr., F.J.
        • Wood Jr., D.P.
        • et al.
        Stent-change therapy in advanced malignancies with ureteral obstruction.
        J Endourol. 2005; 19: 63-67
        • Kaul R.
        • McGeer A.
        • Norrby-Teglund A.
        • et al.
        Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome–a comparative observational study. The Canadian Streptococcal Study Group.
        Clin Infect Dis. 1999; 28: 800-807
        • Lo W.T.
        • Cheng S.N.
        • Wang C.C.
        • et al.
        Extensive necrotising fasciitis caused by Pseudomonas aeruginosa in a child with acute myeloid leukemia: case report and literature review.
        Eur J Pediatr. 2005; 164: 113-114
        • Duncan B.W.
        • Adzick N.S.
        • deLorimier A.A.
        • et al.
        Necrotizing fasciitis in two children with acute lymphoblastic leukemia.
        J Pediatr Surg. 1992; 27: 668-671
        • Mantadakis E.
        • Pontikoglou C.
        • Papadaki H.A.
        • et al.
        Fatal Fournier's gangrene in a young adult with acute lymphoblastic leukemia.
        Pediatr Blood Cancer. 2007; 49: 862-864
        • Dellinger R.P.
        • Levy M.M.
        • Carlet J.M.
        • et al.
        Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
        Crit Care Med. 2008; 36: 296-327
        • Rivers E.
        • Nguyen B.
        • Havstad S.
        • et al.
        Early goal-directed therapy in the treatment of severe sepsis and septic shock.
        N Engl J Med. 2001; 345: 1368-1377
        • Bernard G.R.
        • Vincent J.L.
        • Laterre P.F.
        • et al.
        Efficacy and safety of recombinant human activated protein C for severe sepsis.
        N Engl J Med. 2001; 344: 699-709
        • Bernard G.R.
        • Margolis B.D.
        • Shanies H.M.
        • et al.
        Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US): a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis.
        Chest. 2004; 125: 2206-2216
        • Abraham E.
        • Laterre P.F.
        • Garg R.
        • et al.
        Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.
        N Engl J Med. 2005; 353: 1332-1341
        • Bernard G.R.
        • Macias W.L.
        • Joyce D.E.
        • et al.
        Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis.
        Crit Care. 2003; 7: 155-163
        • Pastores S.M.
        • Papadopoulos E.
        • van den Brink M.
        • et al.
        Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein C.
        Bone Marrow Transplant. 2002; 30: 131-134
        • Pastores S.M.
        • Shaw A.
        • Williams M.D.
        • et al.
        A safety evaluation of drotrecogin alfa (activated) in hematopoietic stem cell transplant patients with severe sepsis: lessons in clinical research.
        Bone Marrow Transplant. 2005; 36: 721-724
        • Marik P.E.
        • Pastores S.M.
        • Annane D.
        • et al.
        Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine.
        Crit Care Med. 2008; 36: 1937-1949
        • Sprung C.L.
        • Annane D.
        • Keh D.
        • et al.
        Hydrocortisone therapy for patients with septic shock.
        N Engl J Med. 2008; 358: 111-124
        • Annane D.
        • Sebille V.
        • Charpentier C.
        • et al.
        Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.
        JAMA. 2002; 288: 862-871
        • Van den Berghe G.
        • Wilmer A.
        • Hermans G.
        • et al.
        Intensive insulin therapy in the medical ICU.
        N Engl J Med. 2006; 354: 449-461
        • van den Berghe G.
        • Wouters P.
        • Weekers F.
        • et al.
        Intensive insulin therapy in the critically ill patients.
        N Engl J Med. 2001; 345: 1359-1367
        • Finfer S.
        • Chittock D.R.
        • Su S.Y.
        • et al.
        Intensive versus conventional glucose control in critically ill patients.
        N Engl J Med. 2009; 360: 1283-1297
        • Sulis M.L.
        • Lauren H.
        • Cairo M.S.
        Granulocyte transfusions in the neonate and child.
        in: Hillyer C.D. Strauss R.G. Luban N.L.C. Handbook of pediatric transfusion medicine. Academic Press, Oxford (UK)2004: 167-180
        • Cebon J.
        • Layton J.E.
        • Maher D.
        • et al.
        Endogenous haemopoietic growth factors in neutropenia and infection.
        Br J Haematol. 1994; 86: 265-274
        • Heuser M.
        • Ganser A.
        • Bokemeyer C.
        Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.
        Semin Hematol. 2007; 44: 148-156
        • Darmon M.
        • Azoulay E.
        • Alberti C.
        • et al.
        Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients.
        Intensive Care Med. 2002; 28: 1775-1780
        • Bouchama A.
        • Khan B.
        • Djazmati W.
        • et al.
        Hematopoietic colony-stimulating factors for neutropenic patients in the ICU.
        Intensive Care Med. 1999; 25: 1003-1005
        • Freireich E.J.
        • Levin R.H.
        • Whang J.
        • et al.
        The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients.
        Ann N Y Acad Sci. 1964; 113: 1081-1089
        • Stanworth S.J.
        • Massey E.
        • Hyde C.
        • et al.
        Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction.
        Cochrane Database Syst Rev. 2005; (CD005339)
        • Chapel H.M.
        • Lee M.
        The use of intravenous immune globulin in multiple myeloma.
        Clin Exp Immunol. 1994; 97: 21-24
        • Morell A.
        • Barandun S.
        Prophylactic and therapeutic use of immunoglobulin for intravenous administration in patients with secondary immunodeficiencies associated with malignancies.
        Pediatr Infect Dis J. 1988; 7: S87-S91
        • Turgeon A.F.
        • Hutton B.
        • Fergusson D.A.
        • et al.
        Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis.
        Ann Intern Med. 2007; 146: 193-203
        • Laupland K.B.
        • Kirkpatrick A.W.
        • Delaney A.
        Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
        Crit Care Med. 2007; 35: 2686-2692
        • Kreymann K.G.
        • de Heer G.
        • Nierhaus A.
        • et al.
        Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
        Crit Care Med. 2007; 35: 2677-2685
        • Warren D.K.
        • Fraser V.J.
        Infection control measures to limit antimicrobial resistance.
        Crit Care Med. 2001; 29: N128-N134
        • Climo M.W.
        • Sepkowitz K.A.
        • Zuccotti G.
        • et al.
        The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial.
        Crit Care Med. 2009; 37: 1858-1865
        • Kollef M.
        SMART approaches for reducing nosocomial infections in the ICU.
        Chest. 2008; 134: 447-456
        • Noyce J.O.
        • Michels H.
        • Keevil C.W.
        Potential use of copper surfaces to reduce survival of epidemic meticillin-resistant Staphylococcus aureus in the healthcare environment.
        J Hosp Infect. 2006; 63: 289-297
        • Weaver L.
        • Michels H.T.
        • Keevil C.W.
        Survival of Clostridium difficile on copper and steel: futuristic options for hospital hygiene.
        J Hosp Infect. 2008; 68: 145-151
        • Johnson J.R.
        • Kuskowski M.A.
        • Wilt T.J.
        Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients.
        Ann Intern Med. 2006; 144: 116-126
        • Kollef M.H.
        • Afessa B.
        • Anzueto A.
        • et al.
        Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial.
        JAMA. 2008; 300: 805-813
        • Ramritu P.
        • Halton K.
        • Collignon P.
        • et al.
        A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units.
        Am J Infect Control. 2008; 36: 104-117
        • Bouza E.
        • Perez M.J.
        • Munoz P.
        • et al.
        Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in the postoperative period of major heart surgery.
        Chest. 2008; 134: 938-946